Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Jan B. Vermorken, Jan Stöhlmacher-Williams, Lisa Licitra, +14

The Lancet Oncology

Metastatic Squamous-cell CarcinomaOpen-label Phase 3MedicinePathologyHead And Neck Cancer +6

Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13

Andrea Luciani, C. Bertuzzi, D. Marussi, +7

Journal of Clinical Oncology

Family MedicineAgingElderly PatientsCancer ManagementEpidemiology Of Cancer +22

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

Michael Henke, M. Alfonsi, Paolo Foa, +8

Journal of Clinical Oncology

Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.

Giovanni Barosi, Achille Ambrosetti, Antonietta Centra, +12

PubMed

Fatigue and Functional Dependence in Older Cancer Patients

Andrea Luciani, Paul B. Jacobsen, Martine Extermann, +4

American Journal of Clinical Oncology

Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.

Paolo Foa, Monica Fornier, Rosalba Miceli, +7

PubMed

Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)

Andrea Luciani, Laura Biganzoli, Giuseppe Colloca, +12

Journal of Geriatric Oncology

Geriatric OncologyOncologyCancer EpidemiologyCancer RiskGeriatrics +9

Water reuse: >90% water yield in MBR/RO through concentrate recycling and CO2 addition as scaling control

Adriano Joss, Claudia Baenninger, Paolo Foa, +6

Water Research

Chemical EngineeringEngineeringWater ReuseEnvironmental EngineeringScaling Control +9

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, +17

Journal of Clinical Oncology

Surgical OncologyInduction TpfPharmacotherapyOral CancerRadiation Medicine +14

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population

Daris Ferrari, Carla Codecà, C. Bertuzzi, +8

BMC Cancer